Yuening Sun

540 total citations · 1 hit paper
13 papers, 361 citations indexed

About

Yuening Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuening Sun has authored 13 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Yuening Sun's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (3 papers) and RNA modifications and cancer (2 papers). Yuening Sun is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (3 papers) and RNA modifications and cancer (2 papers). Yuening Sun collaborates with scholars based in China, United States and Canada. Yuening Sun's co-authors include Qinglong Guo, Libin Wei, Ye Xu, Jingyue Yao, Yongjian Guo, Jubo Wang, Jian Liu, Shu Xu, Yuanming He and Xinliang Mao and has published in prestigious journals such as Free Radical Biology and Medicine, European Journal of Pharmacology and Cancer Letters.

In The Last Decade

Yuening Sun

13 papers receiving 358 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma

2021 155 citations Jingyue Yao, Jubo Wang et al. Autophagy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuening Sun China	9	240	98	73	60	52	13	361
Lili Yan China	11	181 0.8×	115 1.2×	63 0.9×	48 0.8×	23 0.4×	18	327
Tijana Tomić Serbia	5	255 1.1×	87 0.9×	71 1.0×	102 1.7×	34 0.7×	6	350
Rongyang Dai China	11	266 1.1×	124 1.3×	121 1.7×	56 0.9×	36 0.7×	21	444
Yannasittha Jiramongkol United Kingdom	8	261 1.1×	52 0.5×	99 1.4×	59 1.0×	26 0.5×	12	373
Zhihong Chen China	10	206 0.9×	61 0.6×	95 1.3×	79 1.3×	37 0.7×	27	361
Stefanie Rakel Germany	6	215 0.9×	95 1.0×	63 0.9×	62 1.0×	24 0.5×	6	315
Junliang Pu China	11	243 1.0×	91 0.9×	124 1.7×	32 0.5×	89 1.7×	22	447
Jun Ouyang China	13	330 1.4×	99 1.0×	159 2.2×	53 0.9×	46 0.9×	29	505
Elena Navarro‐Villarán Spain	10	224 0.9×	56 0.6×	101 1.4×	42 0.7×	70 1.3×	17	397

Countries citing papers authored by Yuening Sun

Since Specialization

Citations

This map shows the geographic impact of Yuening Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuening Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuening Sun more than expected).

Fields of papers citing papers by Yuening Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuening Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuening Sun. The network helps show where Yuening Sun may publish in the future.

Co-authorship network of co-authors of Yuening Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yuening Sun. A scholar is included among the top collaborators of Yuening Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuening Sun. Yuening Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

He, Yuanming, Shuoyi Jiang, Yao‐Li Cui, et al.. (2024). Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis. Cancer Letters. 588. 216797–216797. 7 indexed citations

Zhang, Xuefeng, Ruitian Zhang, Yuening Sun, et al.. (2023). AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations. Cancer Letters. 566. 216240–216240. 14 indexed citations

He, Yuanming, et al.. (2023). Proteasomal inhibitors induce myeloma cell pyroptosis via the BAX/GSDME pathway. Acta Pharmacologica Sinica. 44(7). 1464–1474. 16 indexed citations

Guo, Yongjian, Yuening Sun, Wenjing Guo, et al.. (2023). Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy. Biomedicine & Pharmacotherapy. 166. 115342–115342. 3 indexed citations

He, Yuanming, Shuoyi Jiang, Xiaoge Wang, et al.. (2023). USP7 promotes non‐small‐cell lung cancer cell glycolysis and survival by stabilizing and activating c‐Abl. Clinical and Translational Medicine. 13(12). e1509–e1509. 19 indexed citations

Sun, Yuening, Peng Lin, Xiumin Zhou, et al.. (2023). TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. International Journal of Biological Sciences. 19(9). 2803–2816. 18 indexed citations

Sun, Yuening, Xin Chen, Siyan Liao, et al.. (2022). Stabilization of MYC G-quadruplex DNA by ruthenium (II) complex overcomes imatinib resistance in chronic myeloid leukemia cells harboring T315I mutation. Genes & Diseases. 10(2). 399–402. 1 indexed citations

Sun, Yuening, et al.. (2022). Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network. Food and Chemical Toxicology. 169. 113450–113450. 25 indexed citations

Yao, Jingyue, Shu Xu, Yuening Sun, et al.. (2021). Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling. Acta Pharmacologica Sinica. 43(4). 1033–1045. 41 indexed citations

10.

Zhou, Yuxin, Yongjian Guo, Y. Zhu, et al.. (2021). Dual PPARγ/ɑ agonist oroxyloside suppresses cell cycle progression by glycolipid metabolism switch-mediated increase of reactive oxygen species levels. Free Radical Biology and Medicine. 167. 205–217. 22 indexed citations

11.

Yao, Jingyue, Jubo Wang, Ye Xu, et al.. (2021). CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy. 18(8). 1879–1897. 155 indexed citations breakdown →

12.

Wen, Chuangyu, Qingyan He, Yuening Sun, et al.. (2020). Pseudolaric acid B induces mitotic arrest and apoptosis in both imatinib-sensitive and -resistant chronic myeloid leukaemia cells. European Journal of Pharmacology. 876. 173064–173064. 7 indexed citations

13.

Sun, Yuening, Jinxiang Wang, Qingyan He, et al.. (2019). Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma. Journal of Experimental & Clinical Cancer Research. 38(1). 453–453. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact